Literature DB >> 16515729

Role for GLUT1 in diabetic glomerulosclerosis.

Charles W Heilig1, Frank C Brosius, Carol Cunningham.   

Abstract

Numerous studies have investigated specific pathways that link diabetes and high extracellular glucose exposure to glomerulosclerosis and mesangial cell extracellular matrix production. However, only in the past ten years has a role for glucose transporters in this process been addressed. Many different glucose transporters are expressed in glomeruli; of these, the GLUT1 facilitative glucose transporter is upregulated in the diabetic renal cortex and in response to glomerular hypertension, as well as in cultured mesangial cells exposed to high glucose. Transgenic mouse and cell models have recently been developed to test the role of GLUT1 in the pathogenesis of glomerulosclerosis with and without diabetes. Clinical studies of GLUT1 alleles performed in humans have identified GLUT1 susceptibility alleles for diabetic nephropathy. Studies are also currently under way to assess the potential role of GLUT1 in nondiabetic renal disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16515729     DOI: 10.1017/S1462399406010490

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  13 in total

1.  GLUT1 enhances mTOR activity independently of TSC2 and AMPK.

Authors:  Carolyn L Buller; Charles W Heilig; Frank C Brosius
Journal:  Am J Physiol Renal Physiol       Date:  2011-05-25

2.  MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes.

Authors:  Nirmalya Dey; Falguni Das; Meenalakshmi M Mariappan; Chandi Charan Mandal; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2011-05-25       Impact factor: 5.157

3.  Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.

Authors:  Hongyu Zhang; MaryLee Schin; Jharna Saha; Kathleen Burke; Lawrence B Holzman; Wanda Filipiak; Thomas Saunders; Minghui Xiang; Charles W Heilig; Frank C Brosius
Journal:  Am J Physiol Renal Physiol       Date:  2010-04-07

4.  Renal function in diabetic nephropathy.

Authors:  Pradeep Kumar Dabla
Journal:  World J Diabetes       Date:  2010-05-15

5.  PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.

Authors:  Esraa M Zakaria; Nabila N El-Maraghy; Ahmed F Ahmed; Abdelmonim A Ali; Hany M El-Bassossy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-21       Impact factor: 3.000

6.  Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.

Authors:  Hongyu Zhang; Jharna Saha; Jaeman Byun; MaryLee Schin; Matthew Lorenz; Robert T Kennedy; Matthias Kretzler; Eva L Feldman; Subramaniam Pennathur; Frank C Brosius
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-30

7.  A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression.

Authors:  Carolyn L Buller; Robert D Loberg; Ming-Hui Fan; Qihong Zhu; James L Park; Eileen Vesely; Ken Inoki; Kun-Liang Guan; Frank C Brosius
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-23       Impact factor: 4.249

8.  Nephron-deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF.

Authors:  Youli Wang; Kathleen O Heilig; Andrew W Minto; Shenglin Chen; Minghui Xiang; David A Dean; Richard C Geiger; Anthony Chang; Dimitrina D Pravtcheva; Martin Schlimme; Dilip K Deb; Ying Wang; Charles W Heilig
Journal:  Lab Invest       Date:  2009-11-16       Impact factor: 5.662

Review 9.  Mouse models of diabetic nephropathy.

Authors:  Frank C Brosius; Charles E Alpers; Erwin P Bottinger; Matthew D Breyer; Thomas M Coffman; Susan B Gurley; Raymond C Harris; Masao Kakoki; Matthias Kretzler; Edward H Leiter; Moshe Levi; Richard A McIndoe; Kumar Sharma; Oliver Smithies; Katalin Susztak; Nobuyuki Takahashi; Takamune Takahashi
Journal:  J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 10.121

Review 10.  Ion channels and transporters in diabetic kidney disease.

Authors:  Denisha Spires; Anna D Manis; Alexander Staruschenko
Journal:  Curr Top Membr       Date:  2019-02-18       Impact factor: 3.049

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.